使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
As a reminder, this call is being recorded. Please proceed.
提醒各位,本次電話會議正在錄音。請繼續。
Gretchen Hommrich - Director of IR
Gretchen Hommrich - Director of IR
Good morning, and welcome to Acadia's First Quarter 2019 Conference Call.
各位早安,歡迎參加 Acadia 2019 年第一季電話會議。
To the extent any non-GAAP financial measure is discussed in today's call, you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by reviewing yesterday's news release under the Investors link.
若今日電話會議中討論任何非 GAAP 財務衡量指標,您亦可在我們網站的「投資人」連結下,查閱昨日新聞稿中該指標與依 GAAP 計算之最直接可比財務衡量指標的調節表。
This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2019 and beyond. For this purpose, any statements made during this call that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements. You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in the company's first quarter news release. And consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義的前瞻性陳述,其中包括但不限於關於 Acadia 對 2019 年及其後預期之季度與年度財務表現的陳述。就此而言,本次電話會議中所作任何非歷史事實之陳述,均可能被視為前瞻性陳述。在不限制前述內容的情況下,「相信」、「預期」、「計畫」、「期望」及類似用語旨在識別前瞻性陳述。特此提醒您,這些陳述可能受到若干重要因素影響(其中包括但不限於)Acadia 向美國證券交易委員會提交之文件以及公司第一季新聞稿中所載之因素。因此,實際營運與結果可能與前瞻性陳述中討論之結果存在重大差異。公司不承擔公開更新任何前瞻性陳述之義務,不論係因新資訊、未來事件或其他原因。
At this time, for opening remarks, I would like to turn the conference over to Chief Executive Officer, Debbie Osteen. Please go ahead.
現在進入開場致詞,我想將電話會議交給執行長 Debbie Osteen。請開始。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Good morning, and thank you for being with us today for our First Quarter Conference Call. I'm here today with Chief Financial Officer, David Duckworth, and other members of our executive management team. David and I each have some remarks about the first quarter and then I will close. Then we'll open the line for your questions.
各位早安,感謝各位今天參加我們的第一季電話會議。今天與我一同出席的有財務長 David Duckworth 以及我們執行管理團隊的其他成員。David 和我將各自就第一季發表一些談話,之後我會作結。接著我們將開放提問。
We are pleased to report a solid start to 2019, with our first quarter financial and operating results in line with expectations. Revenues increased 2.5% over the first quarter last year. We have continued to drive organic growth within our existing facilities by expanding our services and adding more bed capacity. Total same facility revenue was up 5.6% for the first quarter compared with the prior year period. This improvement included a 2.8% increase in patient days and a 2.7% increase in revenue per patient day.
我們很高興報告 2019 年有一個穩健的開局,第一季財務與營運結果符合預期。營收較去年第一季成長 2.5%。我們持續透過擴增服務並增加床位容量,在既有機構內推動有機成長。第一季同院營收(same facility revenue)較去年同期成長 5.6%。此改善包含病人日(patient days)增加 2.8%,以及每病人日營收增加 2.7%。
During the first quarter, we added 260 beds, increasing our size and geographic scale and further enhancing our position as a leading provider of behavioral health care services. These expansions included 100 beds to existing facilities and 160 beds for the 2 de novo facilities we opened in February, Mount Carmel and Rio Vista. As previously announced, we also acquired the Whittier Pavilion, a 71-bed facility; and Mission Treatment, which owned and operated 9 comprehensive treatment centers.
第一季期間,我們新增 260 張床位,擴大規模與地理覆蓋,並進一步鞏固我們作為行為健康照護服務領先供應商的地位。這些擴建包括既有機構新增 100 張床位,以及我們於 2 月開設的兩家新設(de novo)機構 Mount Carmel 與 Rio Vista 共新增 160 張床位。如先前所宣布,我們亦收購 Whittier Pavilion(71 床機構)以及 Mission Treatment(擁有並營運 9 家綜合治療中心)。
We're excited to announce an expansion of one of our premier facilities, Sierra Tucson. The new 30,000 square foot lodge will include an additional 44 beds, expanded facilities for individualized treatment and a dedicated admission center. The addition is expected to open later in the second quarter. Through the expanded capacity, we will help meet the growing demands of those struggling with substance abuse.
我們很高興宣布擴建我們的旗艦機構之一 Sierra Tucson。新的 30,000 平方英尺旅館式大樓將新增 44 張床位、擴充個人化治療設施,並設置專屬入院中心。預計該新增設施將於第二季稍晚啟用。透過擴增容量,我們將協助滿足正在與物質濫用奮戰者日益增加的需求。
Acadia's integrated behavioral health partnerships continue to be a key growth area for the company. We are currently in more than 20 joint venture partnership discussions with large health systems, including many nonprofit systems and hospitals around the country. We are very excited about our recently announced joint venture partnership to build 120 bed hospitals with Scripps Health in San Diego.
Acadia 的整合式行為健康合作夥伴關係仍是公司關鍵的成長領域。目前我們正與大型醫療體系進行超過 20 項合資合作洽談,其中包括全國各地許多非營利體系與醫院。我們對近期宣布與聖地牙哥的 Scripps Health 合資興建 120 床醫院的合作案感到非常振奮。
During the first quarter, our U.S. operations performed well with favorable trends in key operating metrics. U.S. same facility revenue increased 6.1% for the first quarter with a 4.3% increase in patient days and a 1.7% increase in revenue per patient day compared with the prior year period. U.S. same facility EBITDA margin was consistent with the first quarter of 2018 at 26.1%.
第一季期間,我們的美國業務表現良好,關鍵營運指標呈現有利趨勢。美國同院營收第一季成長 6.1%,相較去年同期,病人日增加 4.3%,每病人日營收增加 1.7%。美國同院 EBITDA 利潤率為 26.1%,與 2018 年第一季一致。
The results from our U.K. operation showed consistent top line growth with same facility revenue up 4.7% consisting of a 0.9% increase in patient days and a 3.7% increase in revenue per patient day. Same facility EBITDA margin was 16.3% for the quarter which is consistent with the fourth quarter of 2018 and with our expectations for the quarter. We remain focused on implementing our plans to improve the operating performance of our U.K. facilities and I'm proud of the hard work our team has put in to execute our plan.
我們英國業務的結果顯示營收端持續成長,同院營收成長 4.7%,其中病人日增加 0.9%,每病人日營收增加 3.7%。本季同院 EBITDA 利潤率為 16.3%,與 2018 年第四季一致,也符合我們對本季的預期。我們仍專注於落實改善英國機構營運表現的計畫,我也為團隊為執行計畫所付出的努力感到自豪。
Now I will turn the call over to David Duckworth to discuss our financial results in more detail.
接下來我將把電話會議交給 David Duckworth,請他更詳細說明我們的財務結果。
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Thanks, Debbie, and good morning. Revenue for the first quarter was $760.6 million, an increase of 2.5% compared with $742.2 million for the first quarter of 2018. On a constant currency basis, adjusting for the year-over-year decline in the exchange rate, revenue growth was approximately 5%.
謝謝 Debbie,各位早安。第一季營收為 7.606 億美元,較 2018 年第一季的 7.422 億美元成長 2.5%。以固定匯率基礎(constant currency)計算,並調整匯率年對年下滑的影響後,營收成長約為 5%。
Net income attributable to Acadia's stockholders was $29.5 million or $0.34 per diluted share for the first quarter of 2019 compared with net income of $50.9 million or $0.58 per diluted share for the first quarter of 2018.
2019 年第一季歸屬於 Acadia 股東的淨利為 2,950 萬美元,或稀釋後每股 0.34 美元;相較之下,2018 年第一季淨利為 5,090 萬美元,或稀釋後每股 0.58 美元。
Adjusted income attributable to Acadia stockholders for the first quarter of 2019 was $34.3 million or $0.39 per diluted share, excluding transaction-related expenses of $4.3 million. Adjusted income attributable to Acadia's stockholders for the first quarter of 2018 was $45.2 million or $0.52 per diluted share, excluding transaction-related expenses of $4.8 million, a tax benefit of $10.5 million due to the Tax Cuts and Jobs Act and debt extinguishment cost of $0.9 million.
2019 年第一季歸屬於 Acadia 股東的調整後淨利為 3,430 萬美元,或稀釋後每股 0.39 美元,已排除 430 萬美元的交易相關費用。2018 年第一季歸屬於 Acadia 股東的調整後淨利為 4,520 萬美元,或稀釋後每股 0.52 美元,已排除 480 萬美元的交易相關費用、因《減稅與就業法案》帶來的 1,050 萬美元稅務利益,以及 90 萬美元的債務清償成本。
The company's consolidated adjusted EBITDA for the first quarter of 2019 was $136 million or 17.9% of revenue. As of March 31, 2019, the company had $72 million outstanding on its $500 million revolving credit facility and a leverage ratio of approximately 5.5x.
公司 2019 年第一季合併調整後 EBITDA 為 1.36 億美元,約占營收的 17.9%。截至 2019 年 3 月 31 日,公司在 5 億美元循環信用額度項下的未償餘額為 7,200 萬美元,槓桿比率約為 5.5 倍。
Turning to our financial guidance and as noted in our news release, we affirmed our guidance for the full year 2019 as follows.: Revenue in a range of $3.15 billion to $3.2 billion; adjusted EBITDA in a range of $610 million to $630 million; adjusted earnings per diluted share in a range of $2.15 to $2.30. And this guidance assumes an exchange rate of $1.30 per British pound sterling and a tax rate of approximately 16%.
接著談我們的財務指引;如新聞稿所述,我們重申 2019 全年指引如下:營收介於 31.5 億至 32 億美元;調整後 EBITDA 介於 6.10 億至 6.30 億美元;稀釋後每股調整後盈餘介於 2.15 至 2.30 美元。此指引假設英鎊兌美元匯率為 1.30,稅率約為 16%。
This concludes my prepared remarks this morning and I'll turn it back over to Debbie for some final comments.
以上為我今天上午預先準備的發言,接下來我將交回給 Debbie 作最後的補充。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Thanks, David. Now that we have covered the results and before we take your questions, I would like to take some time this morning to update you on our strategic review process.
謝謝你,David。現在我們已經說明了業績,在回答各位提問之前,我想利用今天上午的時間,向各位更新我們的策略檢討流程。
As I discussed on the fourth quarter earnings call, we are undertaking a comprehensive review of the business in order to maximize shareholder value, including engaging a third-party management consulting firm. With their help, the Board and senior management are closely evaluating every aspect of our business to determine where we can optimize performance both in the U.S. and the U.K. and across service lines. We have made significant progress to date and continue to review and refine the findings in real time. As the Board and I continued to digest the analysis and potential implications, I expect to be in position to outline our core strategy for the business later this month.
正如我在第四季財報電話會議中提到的,我們正在進行一項全面性的業務檢討,以最大化股東價值,其中包括聘請第三方管理顧問公司。在他們的協助下,董事會與高階管理團隊正密切評估我們業務的各個面向,以判斷我們能在哪些地方優化美國與英國的營運表現,以及各服務線的表現。截至目前我們已取得顯著進展,並持續即時檢視與精煉相關發現。隨著董事會與我持續消化分析結果及其可能的影響,我預期在本月稍晚能夠提出本公司業務的核心策略大綱。
While we expect to have more concrete steps at the end of May, I also want to ensure we continue to maintain our leading position, strong financial performance and unwavering focus on delivering quality care. I look forward to further communicating my vision on a conference call scheduled for Thursday, May 30.
雖然我們預期在五月底會有更具體的步驟,我也希望確保我們能持續維持領先地位、強勁的財務表現,以及對提供高品質照護的堅定專注。我期待在預定於5月30日(週四)舉行的電話會議上,進一步傳達我的願景。
I also want to briefly address the recent press reports and rumors regarding the potential sale of the U.K. division. It is our company's policy not to comment on rumors or speculation. That's all we will say today on this topic so we ask that you keep your questions focused on our results.
我也想簡要回應近期媒體報導與傳聞,內容涉及可能出售英國事業部。本公司政策是不對傳聞或臆測發表評論。今天我們對此議題就說到這裡,因此也請各位將問題聚焦在我們的業績表現。
I will now ask the operator to open the floor for your questions.
接下來我將請接線員開放各位提問。
Operator
Operator
(Operator Instructions) And we'll take our first question from Brian Tanquilut with Jefferies.
(接線員指示) 我們的第一個問題來自Jefferies的Brian Tanquilut。
Jason Michael Plagman - Equity Associate
Jason Michael Plagman - Equity Associate
It's Jason Plagman on for Brian. Just wanted to get an update on the performance of some of the de novos you've opened over the last quarter and also the last 12 months. How are those tracking versus your expectations and what you're seeing for EBITDA drag or positive contributions through the remainder of 2019?
我是代替Brian的Jason Plagman。想請教一下,過去一季以及過去12個月你們新設(de novo)據點的營運表現更新。這些據點相較於你們的預期進度如何?以及在2019年剩餘期間,你們看到的EBITDA拖累或正向貢獻會是什麼情況?
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Jason, this is David. We do have 4 facilities that we have opened in the last 12 months, 2 of those are hitting the point where we expect them to be at breakeven after opening about 12 months ago. Both of those are performing well, very happy with the results there and the progress they've made here in the first year of operations. The 2 more recent facilities, we did open 2 facilities during the first quarter. That's our Rio Vista and our Mount Carmel facilities. Those facilities are going through their survey, licensing and startup processes. One of those has successfully completed its survey with the other one happening very soon. And we did see a loss mainly related to those 2 recent facilities of around $2.5 million during the first quarter. Over the remainder of the year, we expect that to reduce significantly, expectation of more like $1 million to $1.5 million in the second quarter, with those facilities as a group breaking even in the second half of the year.
Jason,我是David。過去12個月我們確實新開了4家機構,其中有2家在開業約12個月後,已達到我們預期的損益兩平點。這兩家表現都很好,我們對那裡的成果以及第一年營運所取得的進展非常滿意。至於較近期的2家機構,我們在第一季開了2家。分別是Rio Vista與Mount Carmel機構。這些機構目前正在進行稽核、執照核發與啟動流程。其中一家已順利完成稽核,另一家也將很快進行。第一季我們確實看到主要與這兩家新機構相關的虧損,約為250萬美元。在今年剩餘期間,我們預期該虧損將顯著下降,第二季預估約為100萬至150萬美元,而這些機構作為一個整體在下半年可達到損益兩平。
Jason Michael Plagman - Equity Associate
Jason Michael Plagman - Equity Associate
Got it. And then switching over to the U.K., it looked like you're seeing stabilization in the same store revenue trends as well as the margins. Any color you can provide on performance during the quarter? Trends during the quarter and what you're seeing as you began Q2?
了解。接著談英國業務,看起來同店營收趨勢以及利潤率都在趨於穩定。能否補充一些本季的表現細節?包括本季內的趨勢,以及你們進入第二季初期所看到的情況?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
This is Debbie. I think that we're seeing a positive from some of the initiatives that we started in 2018 with respect to retooling beds. I think that the team has done a good job of getting those back online at a higher net revenue. We also have other beds that we've taken off recently to, again, respond to NHS and their need for higher acuity services. So there's an offset there for the first quarter in particular. But we expect to bring those beds back online, most of them at the end of May and some through the summer.
我是Debbie。我認為我們正看到一些正面成效,來自於我們在2018年啟動、針對床位重新配置(retooling beds)的措施。我認為團隊在讓這些床位重新上線、並以更高的淨營收水準運作方面做得很好。我們最近也再度暫停了一些其他床位,以回應NHS對更高病情嚴重度(acuity)服務的需求。因此第一季特別會有一些相互抵銷的影響。但我們預期會讓這些床位重新上線,多數在五月底,部分會延續到夏季期間。
We also have been pleased with the fact that we are -- have been successful in collaborating with NHS on some of our fees. And I think that NHS has worked very well with the team to recognize the cost of some of the high-acuity patients. So we have seen actually a higher percent of fees than we would have expected, but we think that frankly, they still don't adequately cover our costs, but I think NHS has made a very good step to try and help with recognizing the high acuity that Priory provides in the country.
我們也很高興看到,我們——一直以來都能成功與NHS就部分費率進行協作。我認為NHS與團隊合作得非常好,能夠認可部分高病情嚴重度患者的成本。因此我們實際上看到費率提高的比例高於原先預期;但坦白說,我們認為這些費率仍不足以充分涵蓋我們的成本。不過我認為NHS已邁出非常重要的一步,試圖協助認可Priory在英國所提供的高病情嚴重度照護。
Jason Michael Plagman - Equity Associate
Jason Michael Plagman - Equity Associate
And then one quick follow-up just on that. So were those increases effective April 1? Or what inflation update did you get on April? And I believe it's the typical timing of those inflation adjustments.
再追問一個很快的問題。這些調升是從4月1日生效嗎?或者你們在4月拿到的通膨調整更新是什麼?我相信這是通膨調整的典型時點。
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Yes. That's right, Jason. The vast majority of our revenue across the different payers in the U.K. and even across the different divisions and services we provide there have an April 1 rate increase. And as Debbie mentioned, we're still working through finalizing that with many of the different payers. That happens not only central NHS but also across the different commissioners in the country. And the rate increase is better this year than what we've seen in the past several years and more reflective of some of the cost increases that we've seen. And we are targeting on average 2.5% to 3% rate increases that will be effective April 1. So that is an improvement compared to an average that we've seen over the last several years of more like 1.5%.
是的。沒錯,Jason。我們在英國不同付款方之間、甚至跨不同事業部與我們提供的各項服務,其絕大多數收入都會在4月1日進行費率調升。如Debbie所提到的,我們仍在與許多不同付款方完成最終定案。這不僅包括中央NHS,也涵蓋全國各地不同的委託方(commissioners)。今年的費率調升幅度優於過去幾年,且更能反映我們所看到的一些成本上升。我們的目標是平均2.5%到3%的費率調升,並自4月1日起生效。相較之下,過去幾年的平均調升幅度更接近1.5%。
Operator
Operator
And we'll take our next question from Pito Chickering with Deutsche Bank.
接下來我們的問題來自德意志銀行(Deutsche Bank)的Pito Chickering。
Philip Chickering - Research Analyst
Philip Chickering - Research Analyst
I guess from a 30,000-foot view perspective, the 2019 guidance has a pretty steep ramp throughout the year. Could you sort of give us -- remind us what the major levers are from a margin perspective that bridges the first quarter to your annual guidance? And also tell us what your implied margins are in both the U.S. and U.K. business within the fourth quarter.
我想從更宏觀的角度來看,2019年的財測指引顯示全年有相當陡峭的逐季爬升。你們能否說明——或提醒我們——從利潤率角度來看,哪些主要槓桿因素能把第一季銜接到你們的全年指引?另外也請告訴我們,你們推算在第四季美國與英國業務各自的隱含利潤率是多少。
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Pito, let me start with the ramp. We do see sequential improvements in both our U.S. and U.K. segments contributing to the improved performance over the remainder of the year. And let me walk you through what we see happening in each of those segments. In the U.S. first, there are seasonal aspects to our first quarter results, including payroll taxes, fewer days in the quarter. So just getting out of the first quarter will be an improvement as it is every year in the U.S.
Pito,我先從逐季爬升談起。我們確實看到美國與英國兩個分部都將逐季改善,並在今年剩餘期間共同推動表現提升。我來帶各位逐一說明我們在各分部所看到的情況。先談美國,第一季的結果有季節性因素,包括薪資稅、以及當季天數較少。因此,只要走出第一季,美國業務就會改善——這在美國每年都是如此。
But then also in the U.S., we have the de novos that I mentioned a minute ago that are improving. We do have 5 facilities that have closed that incurred some cost in the first quarter, in line with what we expected and talked about on our last call. But over the course of the year, the loss that we saw in the first quarter, which was around $2 million for those facilities, will improve and will become closer to just breakeven over the remainder of the year. And then we completed acquisitions during the quarter. Those should mature as well similar to the de novos.
此外在美國,我剛才提到的新設(de novo)據點也在改善。我們確實有5家已關閉的機構在第一季產生了一些成本,符合我們的預期,也如同我們在上次電話會議中所討論的。但在今年的過程中,第一季看到的虧損(這些機構約200萬美元)將會改善,並在今年剩餘期間更接近損益兩平。另外,我們在本季完成了併購。這些併購案也應會逐步成熟,情況與新設據點類似。
And then most importantly, in the U.S., the same facility census growth and earnings growth, the result of the beds that we have added over the last 12 months, will contribute to sequential improvement in the U.S. results. So definitely think the U.S. will be a contributor to continued improvement over the course of the year.
然後最重要的是,在美國,同店的住院人次(census)成長與獲利成長——也就是我們在過去12個月新增床位所帶來的成果——將有助於美國業績的逐季改善。因此,請務必認為美國將在全年持續改善的過程中扮演貢獻者。
In the U.K., we mentioned that we are seeing some stability and even some slight improvements in the labor costs that we're incurring there with both labor and the agency component of that. We see that stabilizing and hopefully continuing to improve. The rate increase, secondly, in the U.K. is contributing to growth over the course of the year. Third in the U.K., we have identified some cost savings opportunities and restructurings that we can do there to help improve the results. Some of those have been implemented over the course of the first quarter and here at the beginning of the second quarter. And then lastly, as Debbie mentioned in the U.K., the retooling, the occupancy improvement and seeing the beds that we have coming online in the later part of the second quarter should contribute to the continuing census improvement, occupancy improvement as we get to the later part of the second quarter and third quarter.
在英國,我們提到,我們看到我們在當地承擔的勞動成本(包含自有員工與派遣人力的部分)出現一些穩定,甚至略有改善。我們看到這種情況正在趨於穩定,並希望能持續改善。其次,在英國,費率上調正在推動全年成長。第三,在英國,我們已辨識出一些可行的成本節省機會與可進行的重整,以協助改善業績。其中部分措施已在第一季期間以及第二季初開始實施。最後,如 Debbie 在英國所提到的,重新調整(retooling)、入住率提升,以及我們在第二季後段將陸續啟用的床位,應可在第二季後段與第三季帶動住院人次持續改善、入住率持續提升。
Philip Chickering - Research Analyst
Philip Chickering - Research Analyst
Just as a sort of -- just a follow-up, could you confirm sort of what the embedded U.S. and U.K. margins are in the fourth quarter within your guidance?
作為一個補充追問,您能否確認一下,在你們的指引中,第四季所隱含的美國與英國利潤率大約是多少?
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Yes. In the U.S., the outlook for the U.K. margin, we have been in the first quarter and in the second half of 2018, at around a 15% margin for the U.K. business in total. We do see that improving to 16%. And then hopefully, an opportunity to continue to improve from there in the second half of the year. But we think that, that improvement does happen in the second quarter from the initiatives that we walked through.
可以。在美國——至於英國利潤率的展望,我們在第一季以及2018年下半年,英國整體業務的利潤率大約在15%左右。我們確實看到它有望改善至16%。然後希望在下半年還有機會在此基礎上持續改善。但我們認為,這項改善會在第二季發生,主要來自我們剛才逐項說明的各項措施。
In the U.S., of course, the first quarter margin does reflect the costs that are unique to the first quarter. And so we see the U.S. margin improving to more like 27% to 28% on a same facility basis. And then the total facility basis will also improve from the same facility basis as well as just the closures and de novos becoming less of a loss number over the remainder of the year. So in total for the U.S. total facility, we would probably see 26% to 27% margins.
在美國,當然,第一季的利潤率反映了第一季特有的成本。因此我們看到美國同店利潤率將改善至約27%到28%。而在全體機構(total facility)口徑下,利潤率也會改善,原因除了同店改善之外,還包括關閉據點與新設據點(de novos)在今年剩餘期間虧損幅度會逐步縮小。因此就美國全體機構而言,我們大概會看到26%到27%的利潤率。
Operator
Operator
And our next question comes from Kevin Fischbeck with Bank of America Merrill Lynch.
下一個問題來自美國銀行美林(Bank of America Merrill Lynch)的 Kevin Fischbeck。
Joanna Sylvia Gajuk - VP
Joanna Sylvia Gajuk - VP
This is Joanna Gajuk filling in for Kevin today. So I guess on the margin question here, specifically for the quarter, so what I'm trying to, I guess, understand is that with this top line growth which is pretty good, right, 6% same store revenues, margins were only flat. So anything on that front? I guess you flagged the de novos being a drag and some of the closures. So would that be -- I guess, because the de novos, I guess, would be excluded from the same store margins. So I'm just trying to understand, how should I think about the same store margin being flat with that very strong same store revenue growth?
今天由 Joanna Gajuk 代替 Kevin 提問。我想就利潤率的問題,特別是針對本季來問:我試著理解的是,在營收端成長相當不錯的情況下——同店營收成長6%——利潤率卻只是持平。這方面有什麼原因嗎?我想你們提到新設據點(de novos)造成拖累,以及一些關閉據點。所以會不會是——因為新設據點應該會被排除在同店利潤率之外。我只是想了解,在同店營收成長非常強勁的情況下,該如何看待同店利潤率仍然持平?
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
That's right, Joanna, the de novos and the closures would be outside of that same facility group. The 26.1% that we saw for our same facility group is a very strong margin for a first quarter, so we are pleased to see that 26.1%. There's nothing to really highlight there. We see the bed additions that have come online in that group performing well as reflected in the top line revenue growth. And we do think the margin improvement year-over-year will be there as we move throughout the year. But there's nothing to highlight there in the first quarter other than we're pleased and that margin is actually is a very strong result for the first quarter.
沒錯,Joanna,新設據點(de novos)與關閉據點都不會納入同店群組。我們同店群組的26.1%利潤率在第一季是非常強勁的,因此我們很高興看到26.1%。這裡其實沒有什麼特別需要強調的。我們看到該群組中已上線的新增床位表現良好,這也反映在營收端的成長上。而且我們確實認為,隨著全年推進,同店利潤率的年增改善會逐步顯現。但第一季除了我們感到滿意之外,沒有其他特別要強調的;而且這個利潤率對第一季而言確實是非常強的結果。
Joanna Sylvia Gajuk - VP
Joanna Sylvia Gajuk - VP
Okay. And I appreciate the commentary on the U.K. fee increase expected April 1. So can you talk about pricing in the U.S.? We know your outlook here and where you're trending this year, and I guess maybe briefly on the outlook, the fact -- that came out, I guess, on the Medicare side calling for like a, I guess, 2% increase for for-profits, psych, freestanding hospitals. So any color, I guess, on the U.S. pricing this year and potential outlook for next year?
了解。也謝謝你們對英國4月1日預期費用上調的說明。那能否談談美國的定價?我們知道你們今年的展望與目前的趨勢;另外也想簡單問一下,Medicare 端我想最近有消息指出,對於營利性精神科獨立醫院(psych, freestanding hospitals)大概是約2%的調升。所以能否分享一些美國今年的定價情況,以及對明年的潛在展望?
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Yes. Sure. We do continue to see strong rate increases in the U.S. as well. Our typical guidance and expectation is in a range of 1.5% to 3%. And we have continued to see pricing at the higher end of that range. I think as you look at our revenue per day statistics that we report, that does reflect the strong pricing growth. And we do see that it can be diluted by outpatient and other revenue, including our CTC revenue. And so those outpatient, other revenue has grown and we've been happy with the growth there. But if it's below the inpatient revenue growth as it has been this quarter, then we see that the dilution of that does impact the revenue per day stat. The Medicare rate increase that has been recently announced, the 1.7%, happy with that, happy with other items that were part of that announcement including the continuation of the prospective payment system methodology. But that is sort of in line with the recent past on Medicare rate increases which have been kind of in that range of 2%.
可以。當然。我們在美國也持續看到強勁的費率上調。我們一貫的指引與預期通常落在1.5%到3%的區間。而我們持續看到定價位於該區間的高端。我想如果你看我們所揭露的每床日營收(revenue per day)統計數據,確實反映了強勁的定價成長。同時我們也看到,該數據可能會被門診與其他收入(包含我們的 CTC 收入)所稀釋。因此,這些門診與其他收入確實成長,我們也對那部分的成長感到滿意。但如果其成長低於住院收入成長——如同本季的情況——那麼這種稀釋效應就會影響每床日營收的統計數據。至於最近公布的 Medicare 費率調升1.7%,我們對此感到滿意,也對該公告中的其他項目感到滿意,包括延續前瞻性支付制度(prospective payment system)的方法論。不過這大致與近年 Medicare 費率調升的趨勢一致,通常大概就在2%左右的區間。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
I'll just add that the inpatient revenue per day has a positive effect from the service mix changes that we've experienced which are a higher percent of acute. And so that should have a favorable impact on our inpatient revenue per day.
我再補充一點:住院每床日營收也會因我們所經歷的服務組合變化而受到正面影響,也就是急性(acute)占比提高。因此,這應該會對我們的住院每床日營收帶來有利影響。
Joanna Sylvia Gajuk - VP
Joanna Sylvia Gajuk - VP
Great. That's very helpful. And if I might close just with the one question, a follow-up on the comment around, I guess, leverage. Where you sit now, you're still at 5.5x. So are you still going to -- expecting to go down to 5x by the end of the year?
很好。這非常有幫助。如果可以的話,我最後再問一個問題,追問一下你們關於槓桿(leverage)的評論。以你們目前的狀況,仍在5.5倍。所以你們是否仍預期在年底前降到5倍?
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Yes. Joanna. That is our outlook that we would be at around this 5.5x level in the first part of the year but closer to 5.1x or so as we get to the end of the year.
是的。Joanna。我們的展望是,上半年大致會在5.5倍左右,但到年底時會更接近約5.1倍。
Operator
Operator
And we'll take our next question from Whit Mayo with UBS.
下一個問題由瑞銀(UBS)的 Whit Mayo 提出。
Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care
Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care
David, I just wanted to go back to the de novo losses and some of the new store losses. What are you actually assuming for the full year within the range now? I think last quarter, maybe you said $1 million to $2 million for the full year in terms of a drag. And was just trying to see whether or not you reclassified any of the same store facilities into the new store bucket this quarter.
David,我想回到新設據點(de novo)虧損以及一些新店虧損的問題。在目前這個區間內,你們對全年實際假設是多少?我記得上季你們可能提到,全年拖累大約是100萬到200萬美元。我也想了解,你們這一季是否把任何原本屬於同店的據點重新分類到新店(new store)類別中。
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Yes. That's a good question, Whit, because we do expect $2 million of losses for the full year 2019. But we will have 2 of the 4 facilities that are included in that number join the same facility group later in the year. And so that is a number that changes depending on what the same facility group is. So just for the 4 facilities right now, it would be around $2 million. However, if you just isolate the 2 that will be in the de novo non-same facility group for the entire year, it would be more like a $4 million loss number between those 2 facilities.
是的。Whit,這是個好問題,因為我們確實預期2019年全年會有200萬美元的虧損。但在今年稍晚,納入該數字的4家機構中會有2家加入同一機構群組。因此,這個數字會隨著「同一機構群組」的界定而變動。所以就目前這4家機構而言,大約會是200萬美元。不過,如果你只單獨看那2家在全年都屬於新設(de novo)且非同一機構群組的機構,那麼這2家機構合計的虧損數字會更接近400萬美元。
Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care
Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care
Okay. All in, $4 million. Okay. That's helpful. Wanted to just go back for a second, just your comments around the stability in the U.K., or I guess your expectation that results will be stable in the U.K. When looking at that reported numbers, your operating costs are growing twice as fast as your revenue. So I'm just wondering what you see today that gives you confidence around labor trends stabilizing. Like, where you're getting the confidence level, where it's coming from. And maybe if you could just confirm where your agency mix is now and how that's trended over the last 2 quarters.
好的。合計400萬美元。好的。這很有幫助。我想再回到你對英國穩定性的評論,或者說你預期英國的結果會保持穩定。但從你們公布的數字來看,你們的營運成本成長速度是營收的兩倍。所以我想知道,你們今天看到什麼,讓你們對勞動力趨勢正在穩定有信心。例如,你們的信心程度從何而來、依據是什麼。另外,也請你確認一下目前你們的派遣人力(agency)占比是多少,以及過去兩個季度的趨勢如何。
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Sure. And we are really -- I think as we talked about on our last quarter call, we've been focused on sequential improvement in the U.K. The second half of 2018 did look different from the first half of 2018. And so as we talk about seeing signs of improvement and stability, we're comparing to the second half of 2018 and we have seen improvement in our agency spend. It's GBP 17 million is the agency spend number during the first quarter. That is an improvement from the third and fourth quarters. And that's about a 12% mix of agency as a percent of total labor cost. That's a great result because we were 13% to 14% in the second half of 2018. So that's the main improvement that we are seeing is around the agency spend going down and the mix of agency going down. And that, combined with the other initiatives around labor, have also resulted in total labor costs going down to below 68% of our revenue. And so that's the improvement that we've seen. A lot of great work has been done in the U.K. to stabilize that and to start to see some improvement there which we expect to continue over the course of the year.
當然。而且我們確實——我想如同我們在上一季電話會議中談到的——一直專注於英國業務的逐季改善。2018年下半年看起來確實與2018年上半年不同。因此,當我們談到看到改善與穩定的跡象時,我們是拿2018年下半年作比較,而我們已看到派遣人力支出有所改善。第一季的派遣人力支出為1,700萬英鎊。這比第三季與第四季有所改善。而派遣人力占總勞動成本的比例約為12%。這是很好的結果,因為在2018年下半年我們是13%到14%。所以我們看到的主要改善,就是派遣人力支出下降,以及派遣人力占比下降。再加上其他與人力相關的措施,也使得總勞動成本下降到低於我們營收的68%。這就是我們看到的改善。英國團隊做了很多很棒的工作來穩定狀況,並開始看到一些改善,我們預期這些改善會在今年持續。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
And I'll just add to what David has said. I think that the team has been focused, which I think is starting to show improvement on hiring permanent staff. And our applications have come up pretty dramatically from both the nursing area and in the non-nursing staff that they've struggled with hiring. I think one of the factors in the U.K. that's been interesting is there have been a number of closures on the retail level. And I think that Priory has been focused on trying to hire some of those individuals and train them to work in the facilities. They've also been very disciplined in using the agencies that they negotiated with last year for lower rates. And we're starting to see that pay off for the group as well. They are really making sure that when an agency person is needed, they are using these preferred groups for the particular facility.
我再補充David所說的。我認為團隊一直很專注,而且我覺得這開始反映在聘用正式員工的改善上。無論是護理領域,或是他們一直難以招募的非護理人員,我們的求職申請數量都大幅上升。英國有一個有趣的因素是,零售層面出現了不少關店。我認為Priory一直專注於嘗試招募其中一些人,並訓練他們到機構內工作。他們在使用派遣人力方面也非常自律,採用去年談判取得較低費率的派遣機構。我們也開始看到這對整個團隊帶來成效。他們確實在確保需要派遣人員時,會針對特定機構使用這些優先合作的團體。
Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care
Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care
That's helpful. Might just slip one more in for David. My notes may be wrong, but I think your revolver may be maturing later this year. Just wanted to hear kind of your latest thoughts, how you're thinking about that. And borrowing capacity, do you think it goes up, not down? Just any thoughts would be helpful.
這很有幫助。我可能再插問David一個問題。我的筆記可能有誤,但我記得你們的循環信貸(revolver)可能會在今年稍晚到期。想聽聽你們最新的想法,你們如何看待這件事。另外,借款額度你覺得會增加,而不是下降嗎?任何想法都很有幫助。
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Yes, Whit, it's actually November of 2021. So we have a few years -- well really, at least 1 year or 2 before we need to be thinking about refinancing that. But that is not happening this year. And as we look at our capital structure and our debt mix, we're still pretty happy with the maturity of that and the pricing of it and the different aspects of our capital structure. But of course, continuing to review what's best for the company there.
是的,Whit,其實是到2021年11月。所以我們還有幾年——更準確地說,至少還有1到2年才需要開始考慮為此再融資。但今年不會發生。而就我們的資本結構與債務組合來看,我們對到期結構、定價以及資本結構的各個面向仍相當滿意。當然,我們也會持續檢視什麼對公司最有利。
Operator
Operator
And we'll take our next question from Matthew Gillmor with Baird.
接下來我們將接聽來自Baird的Matthew Gillmor的提問。
Matthew Dale Gillmor - Senior Research Analyst
Matthew Dale Gillmor - Senior Research Analyst
I wanted to ask about the U.S. length of stay metric. I think it goes down 2.6% on a same store basis. Just wanted to confirm that was a function of your service mix or see if there's anything else to call out on that metric.
我想問一下美國的平均住院天數(length of stay)指標。我認為在同店基礎上下降了2.6%。想確認這是否是你們服務組合的因素所致,或是這個指標還有其他需要特別說明的地方。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Yes. Matthew, it's really a function of the service mix change. The actual length of stay for acute is consistent with what it's been in the last few years. So there's been no change or drop in length of stay with acute. It's just really moving from the higher -- to the higher acute mix.
是的。Matthew,這主要是服務組合變化所致。急性照護(acute)的實際住院天數與過去幾年一致。所以急性照護的住院天數沒有變化或下降。主要只是從較高——轉向較高的急性照護占比。
Matthew Dale Gillmor - Senior Research Analyst
Matthew Dale Gillmor - Senior Research Analyst
Got it. And then one more on the JV pipeline. I was hoping you could characterize overall activity levels. And then more specifically, I was curious if you're seeing greater dialogue with smaller systems with 1 to 2 hospitals or with some of the larger systems. And if there's any opportunity with those larger systems to have a comprehensive relationship. Or the dialogue's sort of more market-by-market?
了解。另外再問一個關於合資(JV)案源管線的問題。我希望你能描述一下整體活動水準。更具體地說,我想知道你們看到與較小的系統(只有1到2家醫院)之間的對話更多,還是與一些較大型的系統更多。以及與那些大型系統是否有機會建立更全面性的合作關係。或者這些對話比較偏向逐個市場(market-by-market)進行?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
I think the JV pipeline is very strong. I think that there are many conversations that we're having with potential partners. And really, we see a mix of both, large systems that have, really, a widespread geographic presence; as well as 1- and 2-hospital systems. But we really see a mix of both and we're very excited about just the opportunity going forward because I think that at this point, the group plans to be a little bit more proactive with that. But these are people seeking out Acadia for the track record that they have around this area. And so we see potential, really, for both large and the smaller systems.
我認為合資案源管線非常強勁。我們正與許多潛在合作夥伴進行對話。而且我們確實看到兩者兼具:既有地理覆蓋範圍很廣的大型系統;也有只有1到2家醫院的系統。但我們確實看到兩者都有,我們對未來的機會感到非常興奮,因為我認為在這個時間點,團隊計畫在這方面更積極一些。不過,這些合作方之所以主動找上Acadia,是因為我們在這個領域的過往實績。因此,我們確實看到大型與小型系統兩方面的潛力。
Operator
Operator
And we'll take our next question from Kevin Ellich with Craig-Hallum.
接下來我們將接聽來自Craig-Hallum的Kevin Ellich的提問。
Kevin Kim Ellich - Senior Research Analyst
Kevin Kim Ellich - Senior Research Analyst
Just following up on the JV partnerships and the plans to add 120 beds with Scripps in San Diego. Is that going to open Q2, Debbie? And then are you still tracking to add about 700 beds this year?
我想延續合資合作夥伴關係的話題,以及與Scripps在聖地牙哥計畫新增120張床位。Debbie,那會在第二季開業嗎?另外,你們今年仍然按計畫新增大約700張床位嗎?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
We are tracking to add close to 700 beds this year. And with respect to Scripps, they're based in San Diego which is California. So there is a process to build, I think you're probably familiar with the OSHPD and other regulatory hurdles that we have to -- we encounter in California. But I will say we target right now 2023. We are actively in our process to start with all of our approvals and I think that's going very well. So we are optimistic we might be able to move that up. But right now, we're looking at 2023.
我們預計今年將新增接近700張病床。至於Scripps,他們位於加州的聖地牙哥。因此在加州要進行建設有一套流程,我想你可能也熟悉OSHPD以及我們在加州必須面對的其他監管障礙。但我會說,我們目前的目標是2023年。我們正積極推進所有核准程序,我認為進展非常順利。所以我們樂觀地認為可能可以把時程提前。但就目前而言,我們仍以2023年為目標。
Kevin Kim Ellich - Senior Research Analyst
Kevin Kim Ellich - Senior Research Analyst
Got it. No, that's helpful. And David, when you look at your free cash flow and CapEx, just wondering if you could give us an update on the outlook as well as how you're thinking about prioritizing uses of discretionary capital. Also noticed some interesting changes in working capital. Anything unusual or more timing-related on that front?
了解。不,這很有幫助。David,當你看你們的自由現金流與資本支出(CapEx)時,想請你也更新一下展望,以及你們如何思考優先配置可自由運用資本的用途。另外也注意到營運資金有一些有趣的變化。那方面有什麼不尋常的情況,或是比較偏時點因素嗎?
David M. Duckworth - CFO, CAO & Controller
David M. Duckworth - CFO, CAO & Controller
Yes. The operating cash flows for the first quarter was in line with our expectation. The first quarter normally is a challenge, with the timing of several items within working capital. And so that was a lower number but it's consistently been a lower number in the past. So really no surprises there. In terms of our use of capital, we did continue to work on adding the 700 beds this year during the quarter and in several other joint venture projects that are in process. And so the capital expenditures for the quarter were close to $70 million. $50 million of that did relate to those expansions, bed addition projects and joint venture projects. So the outlook there is the first quarter is in line with our expectations for the year. We do think $275 million to $30 million (sic) [$300 million] of expansion CapEx spend is our estimate for the year. And what we saw in the first quarter was in line with that. And of course, we're reviewing use of capital in other topics similar to that, just as we go through the strategic review process. And so we'll have more updates on that to follow later in the month.
是的。第一季的營運現金流符合我們的預期。第一季通常比較具挑戰性,因為營運資金中有幾個項目的時點因素。因此數字會比較低,但過去也一直都是較低的水準。所以基本上沒有什麼意外。就資本運用而言,本季我們持續推進今年新增700張病床的工作,以及數個正在進行中的其他合資專案。因此本季資本支出接近7,000萬美元。其中5,000萬美元與這些擴建、增床專案及合資專案相關。所以就展望而言,第一季的表現符合我們對全年預期。我們認為全年擴張性資本支出約為2.75億至3,000萬美元(原文口誤)[3億美元],這是我們對今年的估計。而第一季所看到的也與此一致。當然,隨著我們進行策略檢視流程,我們也會就其他類似議題持續檢視資本運用。因此本月稍晚我們會再提供更多更新。
Operator
Operator
And we'll take our next question from Ana Gupte with SVB Leerink.
接下來我們將接聽SVB Leerink的Ana Gupte的提問。
Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst
Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst
Debbie, I was curious, now that you've spent a little bit more time at Acadia, as you contrast the businesses at -- in UHS relative to Acadia, how do you -- what sort of insights would you be able to share with us? Acadia has CRC Health, the much more robust substance abuse portfolio. We generally had heard from Joey that in the markets they've been in, clinical -- the staffing issue has been less pressing. Also, if you can comment on the capital deployment approaches, reimbursement and regulatory considerations and how the culture and the philosophy is of one company relative to the other.
Debbie,我很好奇,現在你在Acadia待的時間更久一些了,當你對比UHS與Acadia的業務時,你能與我們分享哪些洞見?Acadia擁有CRC Health,物質濫用的產品組合更為強健。我們一般從Joey那邊聽到,在他們所處的市場中,臨床端——人力配置問題的壓力較小。另外,也請你評論一下資本部署方式、給付(reimbursement)與監管考量,以及兩家公司在文化與理念上的差異。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Well, Ana, I think I mentioned this a little bit in the last call, but I've been very pleased with -- just to see the diversification that's here at Acadia. I think the portfolio that exists, which we certainly are reviewing in our strategy process, but the platform and portfolio, I think, is very well positioned to really meet what I consider the key areas of demand. And I believe that they're not overly concentrated in any one state. And then you add to that the diversification that exists within the acute and the substance use and specialty as well as the CTC, I think really positions Acadia to meet the demand.
Ana,我想我在上次電話會議中稍微提到過,但我對——看到Acadia在這裡的多元化感到非常滿意。我認為現有的產品組合——我們當然也正在策略流程中檢視——但這個平台與組合,我認為非常有利於真正滿足我所認定的關鍵需求領域。而且我相信他們在任何單一州都沒有過度集中。再加上急性照護、物質使用與專科服務,以及CTC內部的多元化,我認為這確實讓Acadia能夠滿足需求。
We have looked at the challenges that are in the regulatory area. I think that Acadia has a very robust compliance and quality focus. And I think that with respect to the challenges that we see with how we're going to grow the facilities and how capital is deployed, I think Acadia's team has a very focused and disciplined approach. I think that they really consider and take a business case from the field, and that's really diving the growth, which I think has been helpful. They identify potential growth areas, and I think that then, the team here reviews that.
我們也檢視了監管領域的挑戰。我認為Acadia在法遵與品質方面的投入非常扎實。至於我們在設施擴張與資本部署上所面臨的挑戰,我認為Acadia團隊採取非常聚焦且自律的做法。我認為他們確實會從第一線提出的商業個案來審視,這也真正推動了成長,我覺得這很有幫助。他們會辨識潛在的成長領域,接著由這裡的團隊進行審查。
And so I have been very, very impressed with the platform that is in place here to support the growth. And I think you can see that in the numbers, in the growth numbers. And I think that, that platform can probably be used even more fully within the various service lines. But I think it is strong and they're doing some innovative things around that.
因此,我對這裡已建立的平台、用以支持成長的能力感到非常、非常印象深刻。我想你也可以從數字、從成長數據中看得出來。而且我認為,這個平台在各個服務線中可能還能被更充分地運用。但我認為它很強,而且他們也在這方面做了一些創新。
I think the good news, again with Acadia, is length of stay is very stable. I think that's reflective of the payer mix but also the attention that they give to documentation as well as positive relationships with the payers. And I think that they have a track record with payers. They've responded well to them with respect to services and making sure that we're putting things in place that they need and that will meet the community needs.
我認為另一個好消息是,就Acadia而言,住院天數(length of stay)非常穩定。我認為這反映了付款方組合(payer mix),也反映了他們對病歷文件(documentation)的重視,以及與付款方之間的良好關係。而且我認為他們在付款方方面有良好的往績。在服務提供上,他們對付款方的回應也做得很好,確保我們建立付款方所需要的機制,並能滿足社區需求。
So I think I've only become more impressed with what I consider to be very diversified service lines as well as meeting demand that's out there across the U.S.
所以我認為,我對我所認定的、非常多元的服務線,以及在全美各地滿足既有需求的能力,只會更加印象深刻。
Operator
Operator
And it appears that we have no further questions at this time. I would like to turn the conference back over to Debra Osteen for any additional or closing remarks.
看起來目前沒有其他提問。我想把電話會議交回給Debra Osteen,請她做任何補充或結語。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Thank you. Thanks again for being with us today and for your interest in Acadia Healthcare. I would like to conclude by thanking all of our employees and clinicians for their dedication and focus on providing the highest quality care to our patients and their families.
謝謝。再次感謝各位今天與我們同在,並對Acadia Healthcare的關注。最後,我要感謝我們所有員工與臨床人員的投入與專注,為病患及其家屬提供最高品質的照護。
If you have additional questions today, please do not hesitate to contact us directly. And have a good day.
如果你今天還有其他問題,請隨時直接與我們聯繫。祝各位有美好的一天。
Operator
Operator
And that does conclude today's conference. Thank you for your participation. You may now disconnect.
今天的電話會議到此結束。感謝各位的參與。您現在可以掛線。